Algiers, January 15, 2026 – Algerian pharmaceutical giant Saidal participated in the Algerian-Indian Pharmaceutical Industry Forum held at the Sheraton Hotel in Algiers. The forum is considered a strategic platform for strengthening bilateral cooperation in the vital pharmaceutical sector.
According to a statement from Saidal, the forum provided a valuable opportunity to explore potential partnerships and collaborations between Algerian and Indian pharmaceutical companies. The event featured bilateral business-to-business (B2B) meetings that brought together executives from Saidal and their Indian counterparts to discuss areas of mutual interest and lay the groundwork for future collaborations.
On the sidelines of the forum, Dr. Swati Vijay Kulkarni, the Ambassador of the Republic of India to Algeria, honored Nabila Benyagzer-Warith, the CEO of Saidal Group. The recognition acknowledged her significant role and contributions to the development of the national pharmaceutical industry and her efforts in fostering international partnerships. This tribute underscores the importance of Saidal’s leadership in advancing Algeria’s pharmaceutical capabilities.
Saidal views the forum as a pivotal opportunity to strengthen and structure industrial cooperation with key Indian partners. The company aims to establish sustainable partnerships based on knowledge transfer, technological exchange, and the strengthening of national expertise. These collaborations are intended to contribute to the development of Algeria’s domestic pharmaceutical production and enhance the country’s pharmaceutical security. The focus is on creating long-term, mutually beneficial relationships that foster innovation and growth within the Algerian pharmaceutical sector.
The participation of Saidal in the Algerian-Indian Pharmaceutical Industry Forum reflects the company’s commitment to expanding its international reach and leveraging global partnerships to improve healthcare outcomes in Algeria. The forum served as a catalyst for future collaborations that will ultimately benefit patients and strengthen the Algerian economy.
